D.E. Shaw & Co’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$797K Buy
219,089
+145,928
+199% +$531K ﹤0.01% 2339
2025
Q1
$140K Sell
73,161
-9,500
-11% -$18.2K ﹤0.01% 2815
2024
Q4
$157K Sell
82,661
-300
-0.4% -$570 ﹤0.01% 2770
2024
Q3
$110K Buy
+82,961
New +$110K ﹤0.01% 2881
2022
Q2
Sell
-22,547
Closed -$16K 4121
2022
Q1
$16K Buy
22,547
+8,154
+57% +$5.79K ﹤0.01% 4106
2021
Q4
$33K Buy
+14,393
New +$33K ﹤0.01% 3851
2021
Q1
Sell
-416,583
Closed -$1.17M 2932
2020
Q4
$1.17M Sell
416,583
-1,613,787
-79% -$4.52M ﹤0.01% 1966
2020
Q3
$5.1M Sell
2,030,370
-291,437
-13% -$731K 0.01% 1179
2020
Q2
$31.5M Buy
2,321,807
+1,009,842
+77% +$13.7M 0.04% 408
2020
Q1
$9.95M Buy
1,311,965
+524,334
+67% +$3.97M 0.02% 757
2019
Q4
$4.98M Buy
787,631
+378,588
+93% +$2.39M 0.01% 1183
2019
Q3
$1.6M Sell
409,043
-117,549
-22% -$461K ﹤0.01% 1663
2019
Q2
$2.55M Buy
526,592
+174,805
+50% +$846K ﹤0.01% 1507
2019
Q1
$2.88M Sell
351,787
-65,391
-16% -$536K ﹤0.01% 1406
2018
Q4
$2.31M Buy
417,178
+312,207
+297% +$1.73M ﹤0.01% 1456
2018
Q3
$927K Buy
104,971
+25,396
+32% +$224K ﹤0.01% 1853
2018
Q2
$794K Buy
79,575
+47,861
+151% +$478K ﹤0.01% 1981
2018
Q1
$302K Sell
31,714
-19,635
-38% -$187K ﹤0.01% 2245
2017
Q4
$764K Sell
51,349
-48,588
-49% -$723K ﹤0.01% 1925
2017
Q3
$1.97M Buy
99,937
+79,459
+388% +$1.56M ﹤0.01% 1476
2017
Q2
$294K Buy
+20,478
New +$294K ﹤0.01% 2148
2017
Q1
Sell
-14,477
Closed -$151K 2396
2016
Q4
$151K Sell
14,477
-8,882
-38% -$92.6K ﹤0.01% 2377
2016
Q3
$211K Sell
23,359
-1,126
-5% -$10.2K ﹤0.01% 2310
2016
Q2
$183K Sell
24,485
-3,215
-12% -$24K ﹤0.01% 2398
2016
Q1
$250K Buy
+27,700
New +$250K ﹤0.01% 2310
2015
Q1
Sell
-14,584
Closed -$170K 2496
2014
Q4
$170K Buy
+14,584
New +$170K ﹤0.01% 2348